Loading...

PetVivo Holdings

OTCPK:PETV
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
PETV
OTCPK
$8M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

PetVivo Holdings, Inc., a biomedical device company, focuses on the licensing and commercialization of medical devices and therapeutics to treat pets and other animals suffering from arthritis and other afflictions in Minneapolis, Minnesota. The last earnings update was 122 days ago. More info.


Add to Portfolio Compare Print
  • PetVivo Holdings has significant price volatility in the past 3 months.
PETV Share Price and Events
7 Day Returns
0%
OTCPK:PETV
0.7%
US Medical Equipment
0.5%
US Market
1 Year Returns
-68.3%
OTCPK:PETV
12.2%
US Medical Equipment
0.8%
US Market
PETV Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
PetVivo Holdings (PETV) 0% 2.8% -38.5% -68.3% -73.2% -95.7%
US Medical Equipment 0.7% 5.3% 1.2% 12.2% 63.1% 94.2%
US Market 0.5% 0.2% 1.1% 0.8% 37.4% 37.5%
1 Year Return vs Industry and Market
  • PETV underperformed the Medical Equipment industry which returned 12.2% over the past year.
  • PETV underperformed the Market in United States of America which returned 0.8% over the past year.
Price Volatility
PETV
Industry
5yr Volatility vs Market

Value

 Is PetVivo Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether PetVivo Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as PetVivo Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for PetVivo Holdings. This is due to cash flow or dividend data being unavailable. The share price is $0.4.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for PetVivo Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are PetVivo Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:PETV PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.23
OTCPK:PETV Share Price ** OTCPK (2019-06-03) in USD $0.4
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 40.75x
United States of America Market PE Ratio Median Figure of 3,091 Publicly-Listed Companies 17.68x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of PetVivo Holdings.

OTCPK:PETV PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:PETV Share Price ÷ EPS (both in USD)

= 0.4 ÷ -0.23

-1.78x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • PetVivo Holdings is loss making, we can't compare its value to the US Medical Equipment industry average.
  • PetVivo Holdings is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does PetVivo Holdings's expected growth come at a high price?
Raw Data
OTCPK:PETV PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.78x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.19x
United States of America Market PEG Ratio Median Figure of 2,125 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for PetVivo Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on PetVivo Holdings's assets?
Raw Data
OTCPK:PETV PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $-0.02
OTCPK:PETV Share Price * OTCPK (2019-06-03) in USD $0.4
United States of America Medical Equipment Industry PB Ratio Median Figure of 183 Publicly-Listed Medical Equipment Companies 4.36x
United States of America Market PB Ratio Median Figure of 5,244 Publicly-Listed Companies 1.79x
OTCPK:PETV PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:PETV Share Price ÷ Book Value per Share (both in USD)

= 0.4 ÷ -0.02

-25.55x

* Primary Listing of PetVivo Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • PetVivo Holdings has negative assets, we can't compare the value of its assets to the US Medical Equipment industry average.
X
Value checks
We assess PetVivo Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. PetVivo Holdings has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is PetVivo Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PetVivo Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.9%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is PetVivo Holdings expected to grow at an attractive rate?
  • Unable to compare PetVivo Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare PetVivo Holdings's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare PetVivo Holdings's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:PETV Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.9%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.9%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.9%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:PETV Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:PETV Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 0 -1 -4
2018-09-30 0 -1 -4
2018-06-30 0 -1 -4
2018-03-31 0 -1 -2
2017-12-31 0 0 -2
2017-09-30 0 0 -2
2017-06-30 0 0 -16
2017-03-31 0 0 -16
2016-12-31 0 0 -17
2016-09-30 0 0 -17
2016-06-30 0 0 -3
2016-03-31 0 -1 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if PetVivo Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if PetVivo Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:PETV Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from PetVivo Holdings Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:PETV Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.23
2018-09-30 -0.22
2018-06-30 -0.22
2018-03-31 -0.14
2017-12-31 -0.12
2017-09-30 -0.13
2017-06-30 -1.49
2017-03-31 -1.73
2016-12-31 -1.90
2016-09-30 -1.97
2016-06-30 -0.32
2016-03-31 -0.46

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if PetVivo Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. PetVivo Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  2. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access PetVivo Holdings's filings and announcements here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess PetVivo Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
PetVivo Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has PetVivo Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare PetVivo Holdings's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • PetVivo Holdings does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare PetVivo Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare PetVivo Holdings's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
PetVivo Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from PetVivo Holdings Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:PETV Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 0.00 -4.42 4.15 0.19
2018-09-30 0.00 -4.36 4.16 0.15
2018-06-30 0.00 -3.94 3.80 0.10
2018-03-31 0.00 -2.34 2.17 0.12
2017-12-31 0.00 -1.82 -12.67 0.11
2017-09-30 0.00 -1.54 -12.57 0.14
2017-06-30 0.01 -15.70 1.99 0.19
2017-03-31 0.01 -15.53 2.15 0.17
2016-12-31 0.01 -16.54 17.31 0.14
2016-09-30 0.00 -16.65 17.14 0.14
2016-06-30 0.00 -2.61 2.75 0.12
2016-03-31 0.08 -3.65 3.16 0.17
2015-12-31 0.08 -2.70 1.77 0.12
2015-09-30 0.08 -2.75 1.35 0.10
2015-06-30 0.08 -2.05 1.28 0.05
2015-03-31 -1.57 1.20 0.00
2014-12-31 -37.92 37.58 0.15
2014-03-31 -36.99 36.85 0.12

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if PetVivo Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if PetVivo Holdings has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if PetVivo Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess PetVivo Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
PetVivo Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is PetVivo Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up PetVivo Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • PetVivo Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • PetVivo Holdings has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of PetVivo Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • PetVivo Holdings has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from PetVivo Holdings Company Filings, last reported 5 months ago.

OTCPK:PETV Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 -0.31 0.15 0.19
2018-09-30 -0.39 0.27 0.04
2018-06-30 -0.05 0.10 0.03
2018-03-31 0.14 0.19 0.24
2017-12-31 0.34 0.38 0.56
2017-09-30 0.11 0.44 0.19
2017-06-30 0.17 0.44 0.01
2017-03-31 0.82 0.43 0.03
2016-12-31 0.02 0.36 0.00
2016-09-30 0.40 0.35 0.01
2016-06-30 14.89 0.35 0.00
2016-03-31 15.21 0.39 0.00
2015-12-31 14.91 1.33 0.02
2015-09-30 14.82 1.12 0.00
2015-06-30 15.79 0.86 0.02
2015-03-31 0.16 0.24 0.04
2014-12-31 -1.85 0.87 0.00
2014-03-31 -0.30 0.21 0.04
  • PetVivo Holdings has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if PetVivo Holdings's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • PetVivo Holdings has less than a year of cash runway based on current free cash flow.
  • PetVivo Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 19.2% each year.
X
Financial health checks
We assess PetVivo Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. PetVivo Holdings has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is PetVivo Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from PetVivo Holdings dividends.
If you bought $2,000 of PetVivo Holdings shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate PetVivo Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate PetVivo Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:PETV Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2011 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as PetVivo Holdings has not reported any payouts.
  • Unable to verify if PetVivo Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of PetVivo Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as PetVivo Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess PetVivo Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can PetVivo Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. PetVivo Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of PetVivo Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • PetVivo Holdings has no CEO, or we have no data on them.
Management Team Tenure

Average tenure and age of the PetVivo Holdings management team in years:

1.4
Average Tenure
58.5
Average Age
  • The average tenure for the PetVivo Holdings management team is less than 2 years, this suggests a new team.
Management Team

David Merrill

TITLE
Co-Chair & Special Revenue Consultant
COMPENSATION
$169K
AGE
70
TENURE
1.3 yrs

John Lai

TITLE
President & Director
COMPENSATION
$126K
AGE
56

John Dolan

TITLE
General Counsel & Director
COMPENSATION
$49K
AGE
53

John Carruth

TITLE
Acting Chief Financial Officer
TENURE
0.5 yrs

Gary DeMel

TITLE
Executive Vice President of Business Development
AGE
61
TENURE
2.8 yrs

Randy Wenthold

TITLE
Chief Science Officer
TENURE
1.5 yrs
Board of Directors Tenure

Average tenure and age of the PetVivo Holdings board of directors in years:

3.6
Average Tenure
59
Average Age
  • The tenure for the PetVivo Holdings board of directors is about average.
Board of Directors

David Merrill

TITLE
Co-Chair & Special Revenue Consultant
COMPENSATION
$169K
AGE
70

Sherry Grisewood

TITLE
Co-Chair
AGE
65

John Lai

TITLE
President & Director
COMPENSATION
$126K
AGE
56
TENURE
5.3 yrs

John Dolan

TITLE
General Counsel & Director
COMPENSATION
$49K
AGE
53
TENURE
5.3 yrs

David Masters

TITLE
Director
COMPENSATION
$78K
AGE
60
TENURE
4.2 yrs

Randall Meyer

TITLE
Director
COMPENSATION
$80K
AGE
54
TENURE
4.2 yrs

John Wagoner

TITLE
Member of Advisory Board
TENURE
3.1 yrs

Brian Barnett

TITLE
Member of Advisory Board
TENURE
3.1 yrs

David Deming

TITLE
Independent Director
COMPENSATION
$49K
AGE
61
TENURE
1.8 yrs

Peter Vezmar

TITLE
Independent Director
COMPENSATION
$49K
AGE
58
TENURE
1.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess PetVivo Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. PetVivo Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

PetVivo Holdings, Inc., a biomedical device company, focuses on the licensing and commercialization of medical devices and therapeutics to treat pets and other animals suffering from arthritis and other afflictions in Minneapolis, Minnesota. Its lead product is Kush System, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company was formally known as Technologies Scan Corp. and changed its name to PetVivo Holdings, Inc. in April 2014. PetVivo Holdings, Inc. was incorporated in 2009 and is headquartered in Edina, Minnesota.

Details
Name: PetVivo Holdings, Inc.
PETV
Exchange: OTCPK
Founded: 2009
$8,217,235
20,543,088
Website: http://www.petvivo.com
Address: PetVivo Holdings, Inc.
5251 Edina Industrial Boulevard,
Edina,
Minnesota, 55439,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK PETV Common Stock Pink Sheets LLC US USD 25. Mar 2014
Number of employees
Current staff
Staff numbers
0
PetVivo Holdings employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/16 00:48
End of day share price update: 2019/06/03 00:00
Last earnings filing: 2019/02/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.